Latest news
Loading news…
Sumitovant
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2019 251-500 employees For Profit
Sumitovant is a biopharmaceutical company focused on developing innovative medicines and therapies for patients.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
82
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 33
- Patents granted
- 0
- Trademarks
- 1
Company Info
- Founded
- 2019
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 1
- News articles
- 9
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- 1.9
Acquisitions by Sumitovant
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Sumitovant
Chief Executive Officer & Founder
Chief Information Officer
82
professional contacts at Sumitovant
Contact execs at Sumitovant →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Sumitovant
Loading news…
FAQs about Sumitovant
People who checked this page also checked these
Sectors Sumitovant invests & acquires in
Browse the full Acquirezy directory.